Navigation Links
Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
Date:5/7/2008

compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the continuation of the collaboration between Arena and Taisho and efforts thereunder; the progress of a Phase 1 clinical trial program under such collaboration, including future results, activities and related payments; the therapeutic, commercial and other potential of the compound in such clinical trial program; and other statements about Arena's outlook, strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to partner lorcaserin, APD125, APD791 or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents, the timing and receipt of payments and fees, if any, from Arena's collaborators, and Arena's ability to redeem with common stock any outstanding
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
10. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
11. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Consolidated Net ... Business Highlights   , India Business grew ... by 9.33% to Rs. 4,886.70 Mn Rest of World ... Europe Formulations Business grew by 34.53% to Rs. 977.26 Mn ... , Glenmark Pharmaceuticals Limited, the research-led global ...
(Date:7/24/2014)... -- Delivery of the Report will take 2-3 ... Photo - http://photos.prnewswire.com/prnh/20140723/129707 ... on Global and Chinese Hemodialysis Machine industry. The ... Machine including its classification, application and manufacturing technology. ... manufacturers of Hemodialysis Machine listing their product specification, ...
(Date:7/24/2014)... Cancer patients in the west of Scotland ... home when a new radiotherapy center opens near ... VAR ) has been selected to equip the new ... TrueBeam™ medical linear accelerators. Two of the ... radiosurgery treatments, will replace older treatment machines at the Beatson ...
Breaking Medicine Technology:Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 2Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 3
... N.J., Feb. 19, UCB (Euronext: UCB) and sanofi-aventis ... (FDA) approved a New Drug,Application (NDA) for XYZAL(R) ... indicated for the relief of,symptoms associated with indoor ... chronic idiopathic urticaria. XYZAL(R) tablets received FDA,approval on ...
... -Study Results Show Cethromycin Not Associated with QT Prolongation- ... -Favorable Cardiac Safety Profile Strengthens NDA-, CHICAGO, ... ADLS ), today announced positive results from Trial,CL07-001, a ... cethromycin. This study was conducted to evaluate the cardiac,safety ...
Cached Medicine Technology:FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria 2FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria 3FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria 4FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria 5Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 2Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 3Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 4Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 5Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 6
(Date:7/24/2014)... Pools and beaches are the place to be on hot ... small children, so Amica Insurance is sharing five ... for Disease Control and Prevention, children between the ages of ... and deaths. It’s important to know the best practices for ... the following tips from the American Red Cross:, ...
(Date:7/24/2014)... caffeine may worsen the hot flashes and night sweats ... through menopause, new survey data suggests. "While these ... intake may be useful for those postmenopausal women who ... Dr. Stephanie Faubion, director of the Women,s Health Clinic ... caffeine -- a stimulant found in coffee and colas ...
(Date:7/24/2014)... 2014 Horizon BCBSNJ’s second annual “Back ... family a rent-free week in a beautiful Lavallette shore ... Don’t miss your chance to win a week’s vacation ... all New Jersey residents, 25 or older.* Residents can ... http://www.facebook.com/HorizonBCBSNJ . , “A family vacation at the ...
(Date:7/24/2014)... PITTSBURGHComputer scientists at Carnegie Mellon University, working with ... Lawrence Berkeley National Laboratory, have devised a computational ... as normal breast cells turn malignant and as ... method for analyzing how genes interact with each ... report published today by the online journal ...
(Date:7/24/2014)... (Boston)--Minority women who received the Human Papillomavirus Vaccination ... rates of abnormal Pap test results than those ... the journal Sexually Transmitted Diseases . ... Health and School of Medicine conducted a cross-sectional ... undergoing routine cervical cytology testing. HPV status and ...
Breaking Medicine News(10 mins):Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:(Beach) Sands of Time Running out to Enter Horizon Blue Cross Blue Shield of New Jersey’s 2014 “Back to the Boardwalk” Sweepstakes 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3
... say , THURSDAY, Feb. 11 (HealthDay News) -- Just ... chocolate appears to lower your risk of stroke or lessen ... the findings, based on a review of existing research, aren,t ... your heart. And dietitians say too much chocolate can be ...
... ... 11 getSTDtested.com, a physician driven, STD ... Goodbye" to encourage young women to take action to prevent chlamydia. ... cured with antibiotic treatment.  The campaign to " Kiss Chlamydia Goodbye " ...
... , MARINA DEL REY, Calif. , Feb. 11 ... Network Family, and CEO Dr. Richard Merkin have ... community service and dedication as a leading health care provider. ... of Commerce of the San Fernando Valley and Region, honored ...
... , , BRENTWOOD, Tenn. , Feb. ... present a free seminar, ADHD Kids: Getting Along Socially , ... at the Maryland Farms YMCA in Brentwood . It is ... Farms YMCA, to help support parents, school teachers, administrators and counselors, ...
... College of Georgia researchers are conducting the first FDA-approved clinical ... umbilical cord blood can improve the quality of life for ... 40 children age 2-12 whose parents have stored cord blood ... Umbilical cord blood is rich in stem cells, which can ...
... says more than 1,500 cases have been reported in New ... In a recent mumps outbreak occurring in the eastern United ... infectious illness got sick, health officials report. , A study ... Prevention tracked an ongoing outbreak of mumps, largely confined to ...
Cached Medicine News:Health News:Dark Chocolate May Lower Stroke Risk 2Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 2Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 3Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 4Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 5Health News:Lakeside Medical Organization, Dr. Richard Merkin, CEO, Honored by United Chambers of Commerce 2Health News:Learning Lab of Brentwood Leads Free ADHD Seminar 2Health News:Learning Lab of Brentwood Leads Free ADHD Seminar 3Health News:MCG to conduct first FDA-approved stem cell trial in pediatric cerebral palsy 2Health News:Vaccine Not Fail-Safe in Ongoing Mumps Outbreak 2Health News:Vaccine Not Fail-Safe in Ongoing Mumps Outbreak 3
... for strength and durability. Four 64 mirrors ... minimal lens rotation. Choice of three handles ... Small diameter contact surface allows static or ... polymer coating protects mirrors and is compatible ...
... Three mirrors of 64, 67 ... diameter contact surface for use ... be viewed through the central ... polymer coating protects mirrors and ...
Small size gonio lens with one 62 mirror. Compact knurled ring simplifies 360 viewing of the anterior chamber angle....
Lacrimal cannula blunt tip with 0.3 mm side port, straight....
Medicine Products: